Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the relationships between HCV, HCV genotype, fatty liver disease, and the metabolic syndrome
- Discuss strategies for screening HCV patients pretreatment for insulin resistance and fatty liver disease
- Summarize strategies for managing insulin resistance and fatty liver disease in patients seeking treatment for chronic hepatitis C
Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.